Ginsenoside Rh2 attenuates the progression of non-small cell lung cancer by sponging miR-28-5p/STK4 axis and inactivating Wnt/β-catenin signaling. [PDF]
Ma J +6 more
europepmc +1 more source
Ginsenoside Rh2- functionalized liposomes enhanced BRD4-PROTAC delivery and antitumor efficacy <i>via</i> improved tumor targeting and ECM remodeling. [PDF]
Wen L +8 more
europepmc +1 more source
Structure Modification of Ginsenoside Rh2 and Cytostatic Activity on Cancer Cells. [PDF]
Liang J +5 more
europepmc +1 more source
Ginsenoside Rh2 Induces HeLa Apoptosis through Upregulating Endoplasmic Reticulum Stress-Related and Downstream Apoptotic Gene Expression. [PDF]
Liu Y +10 more
europepmc +1 more source
Ginsenoside Rh2 as a novel PIN1 inhibitor disrupting the cancer stem cell-like phenotype in non-small cell lung cancer. [PDF]
Liu X +8 more
europepmc +1 more source
Ginsenoside Rh2 repressed the progression of prostate cancer through the mitochondrial damage induced by mitophagy and ferroptosis. [PDF]
He Z +5 more
europepmc +1 more source
Ginsenoside Rh2 Suppresses Metastasis and Growth of Colon Cancer via miR-491. [PDF]
Wei W +6 more
europepmc +1 more source
Ginsenoside Rh2 targets SIRT1-mediated deacetylation to modulate ERα/AR balance and overcome endocrine therapy resistance in prostate cancer using 3D organoid models. [PDF]
Chen X +7 more
europepmc +1 more source
Ginsenoside Rh2-Pretreated Mesenchymal Stem Cell Exosomes Ameliorate Collagen-Induced Arthritis via N6-Methyladenosine Methylation. [PDF]
Zhou Z, Wu S, Li Y, Shao P, Jiang J.
europepmc +1 more source
Ginsenoside Rh2 mitigates doxorubicin-induced cardiotoxicity by inhibiting apoptotic and inflammatory damage and weakening pathological remodelling in breast cancer-bearing mice. [PDF]
Hou J, Yun Y, Cui C, Kim S.
europepmc +1 more source

